Today's News | Note: News feeds may no longer be available for the articles on this page.

Peregrine cancer drug shows promise in mid-stage study 12:29 PM 2/4/2009
Reuters - USA
Peregrine Pharmaceuticals Inc's experimental drug bavituximab for the treatment of lung cancer met the main goal in a mid-stage study. ...

Roche Results Make For Tough Swallow 5:20 AM 2/4/2009
Forbes - NY,USA
Roche ramped up its efforts to buy rival Genentech and disappointed investors with a set of annual results that missed expectations. ...

US panel backs Lilly, Daiichi anti-clotting drug 5:21 PM 2/3/2009
Reuters - USA
Eli Lilly and Daiichi Sankyo won unanimous support from the advisory panel to approve prasugrel which would offer an alternative to Plavix and its more than $7 billion in global sales. ...

ViroPharma genetic disease drug gets fast review 12:55 PM 2/3/2009
Reuters - USA
ViroPharma Inc's drug application for Cinryze will receive a priority review as a treatment for acute attacks of hereditary angioedema (HAE). Cinryze is already approved for the preventive treatment of HAE. ...

BioMarin says arterial disease drug misses main goal 11:02 AM 2/3/2009
Reuters - USA
A mid-stage study of BioMarin Pharmaceutical Inc's 6R-BH4 candidate to treat peripheral arterial disease (PAD) did not show a significant difference when compared to a dummy. ...

Immupharma jumps on deal with Cephalon 7:11 AM 2/3/2009
Forbes - NY,USA
Shares in Immupharma hit a two year high after US partner Cephalon pays $30 million to license the worldwide rights to lupus drug Lupuzor. ...

InterMune lung drug meets goal in trial 6:54 AM 2/3/2009
Reuters - USA
InterMune Inc said pirfenidone used in the treatment of idiopathic pulmonary fibrosis failed to meet the main goal of the CAPACITY 1 trial, but in CAPACITY 2, met both the primary and key secondary endpoints. ...

Stimulant drugs cause cocaine-like brain changes 5:12 AM 2/3/2009
Reuters - USA
Novartis' Ritalin (methylphenidate) used to treat attention deficit hyperactivity disorder (ADHD) may cause brain changes similar to those seen in cocaine addicts. ...

Synta launches phase 3 cancer-drug trial 2:49 PM 2/2/2009
Bizjournals.com - Charlotte,NC,USA
Synta Pharmaceuticals has completed enrollment of 630 patients for its phase 3 clinical trial in support of elesclomol to treat metastatic melanoma. ...

FDA cites allergic reactions with Dyax drug 1:08 PM 2/2/2009
Forbes - NY,USA
Dyax has asked the US FDA to approve its drug ecallantide to treat hereditary angioedema. It's a genetic protein deficiency that can cause swelling of the face, hands, and larynx. ...

FTC challenges Par-Solvay patent settlement 12:12 PM 2/2/2009
Reuters - USA
Par Pharmaceutical Cos Inc said a lawsuit filed by Federal Trade Commission (FTC) and the California attorney general made antitrust allegations about the 2006 patent settlement which allowed Par to market the generic version of AndroGel 1 percent in August 2015. ...

Wyeth deal could mean NJ drug industry job cuts 5:25 AM 2/2/2009
Forbes - NY,USA
The Garden State will suffer disproportionately from drugmaker cost cutting and consolidation because it is the nation's medicine chest. ...

Reports: GlaxoSmithKline to cut thousands of jobs 4:28 AM 2/2/2009
International Herald Tribune - France
GlaxoSmithKline could eliminate up to 10,000 jobs around the world as part of its ongoing restructuring program. ...

Tax Cheat to Head Up Health and Human Services 7:59 AM 2/1/2009
Washington Post - United States
Former SD Senator Tom Daschle waited a month after his nomination as secretary of DHHS before informing President Obama he had not paid years of back taxes over $140K. Sounds like the right character to help the US FDA right the ship. ...

FDA Panel Urges Ban On Painkiller Darvon 7:53 AM 1/31/2009
Washington Post - United States
Consumer group Public Citizen thinks the US FDA should withdraw Darvon because the drug offers weak pain relief and poses an overdose risk. ...

<- Day Earlier | Today's News